Answers are grounded in this paper and cite their sources.
The Trail Walking Test (TWT) assesses complex walking through visual scanning, sequential target identification, and repeated directional changes. This study investigated its test-retest reliability and preliminary validity in people with Parkinson's disease. Thirty-four people with Parkinson's disease participated in this cross-sectional methodological study. Test-retest reliability was assessed using the intraclass correlation coefficient (ICC), SEM, and minimal detectable change at the 95% confidence level (MDC95). Convergent validity was examined through correlations with clinical measures. Known-groups validity was assessed according to fall history and freezing of gait (FoG) status. Receiver operating characteristic (ROC) analyses were exploratory. The TWT demonstrated excellent test-retest reliability [ICC = 0.955, 95% confidence interval (CI): 0.911-0.977], with an SEM of 5.0 s and MDC95 of 13.8 s. TWT completion time was strongly correlated with motor symptom severity (r = 0.844), FoG severity (r = 0.833), Trail Making Test Part A performance (r = 0.808), and cognitive-motor interference during the Timed Up and Go Test (r = 0.756). Completion time was longer in participants with a history of falls and those classified as freezers (both P < 0.001). Exploratory ROC analyses yielded area under the curve of 0.911 (95% CI: 0.816-1.000) for fall history and 0.937 (95% CI: 0.862-1.000) for FoG status. These preliminary findings support the reliability and provide initial evidence of the validity of the TWT in people with Parkinson's disease. The TWT may provide complementary information about complex walking performance. The ROC findings should be interpreted cautiously and require confirmation in larger, independent samples before clinical application can be considered.
No takes yet. Share an insight, caveat, or question.
Gülşen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: